SMMT
Price
$16.98
Change
-$1.59 (-8.56%)
Updated
Dec 18, 04:59 PM (EDT)
85 days until earnings call
VBIZF
Price
$0.11
Change
-$0.06 (-35.29%)
Updated
Nov 27 closing price
Ad is loading...

SMMT vs VBIZF

Header iconSMMT vs VBIZF Comparison
Open Charts SMMT vs VBIZFBanner chart's image
Summit Therapeutics
Price$16.98
Change-$1.59 (-8.56%)
Volume$53.28K
CapitalizationN/A
Viva Biotech Holdings
Price$0.11
Change-$0.06 (-35.29%)
Volume$3.5K
CapitalizationN/A
SMMT vs VBIZF Comparison Chart
Loading...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SMMT vs. VBIZF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMMT is a Hold and VBIZF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (SMMT: $18.57 vs. VBIZF: $0.11)
Brand notoriety: SMMT and VBIZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SMMT: 95% vs. VBIZF: 184%
Market capitalization -- SMMT: $13.69B vs. VBIZF: $233.78M
SMMT [@Biotechnology] is valued at $13.69B. VBIZF’s [@Biotechnology] market capitalization is $233.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMMT’s FA Score shows that 2 FA rating(s) are green whileVBIZF’s FA Score has 1 green FA rating(s).

  • SMMT’s FA Score: 2 green, 3 red.
  • VBIZF’s FA Score: 1 green, 4 red.
According to our system of comparison, SMMT is a better buy in the long-term than VBIZF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMMT’s TA Score shows that 4 TA indicator(s) are bullish while VBIZF’s TA Score has 4 bullish TA indicator(s).

  • SMMT’s TA Score: 4 bullish, 3 bearish.
  • VBIZF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, VBIZF is a better buy in the short-term than SMMT.

Price Growth

SMMT (@Biotechnology) experienced а +3.34% price change this week, while VBIZF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

SMMT is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($13.7B) has a higher market cap than VBIZF($248M). SMMT YTD gains are higher at: 611.494 vs. VBIZF (-7.942).
SMMTVBIZFSMMT / VBIZF
Capitalization13.7B248M5,524%
EBITDA-183.16MN/A-
Gain YTD611.494-7.942-7,700%
P/E Ratio26.36N/A-
Revenue0N/A-
Total Cash487MN/A-
Total Debt32.5MN/A-
FUNDAMENTALS RATINGS
SMMT: Fundamental Ratings
SMMT
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SMMTVBIZF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
52%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Ad is loading...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OKYO1.090.05
+4.80%
OKYO Pharma Limited
DAWN12.640.02
+0.16%
Day One Biopharmaceuticals
SLM27.68-0.07
-0.25%
SLM Corp
NEM39.80-0.28
-0.70%
Newmont Corp
MG9.08-0.16
-1.73%
Mistras Group

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-0.59%
BCDA - SMMT
70%
Closely correlated
+0.47%
VBIZF - SMMT
42%
Loosely correlated
N/A
DAWN - SMMT
32%
Poorly correlated
+0.16%
ERNA - SMMT
31%
Poorly correlated
-3.61%
IDYA - SMMT
30%
Poorly correlated
+1.07%
More

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with SMMT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
SMMT - VBIZF
42%
Loosely correlated
-0.59%
BCLI - VBIZF
35%
Loosely correlated
+15.48%
AKBLF - VBIZF
24%
Poorly correlated
N/A
ACHL - VBIZF
24%
Poorly correlated
-2.02%
SRBCF - VBIZF
12%
Poorly correlated
-2.00%
More